|
Gene: ITPKC |
Gene summary for ITPKC |
Gene summary. |
Gene information | Species | Human | Gene symbol | ITPKC | Gene ID | 80271 |
Gene name | inositol-trisphosphate 3-kinase C | |
Gene Alias | IP3-3KC | |
Cytomap | 19q13.2 | |
Gene Type | protein-coding | GO ID | GO:0006066 | UniProtAcc | A0A024R0N8 |
Top |
Malignant transformation analysis |
Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
Malignant transformation involving gene list. |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
80271 | ITPKC | CA_HPV_2 | Human | Cervix | CC | 6.83e-03 | 2.36e-01 | 0.0391 |
80271 | ITPKC | CCI_1 | Human | Cervix | CC | 6.45e-04 | 5.15e-01 | 0.528 |
80271 | ITPKC | CCI_2 | Human | Cervix | CC | 1.83e-02 | 4.79e-01 | 0.5249 |
80271 | ITPKC | CCI_3 | Human | Cervix | CC | 9.52e-05 | 5.49e-01 | 0.516 |
80271 | ITPKC | CCII_1 | Human | Cervix | CC | 2.87e-02 | 3.15e-01 | 0.3249 |
80271 | ITPKC | sample3 | Human | Cervix | CC | 8.12e-08 | 3.03e-01 | 0.1387 |
80271 | ITPKC | H2 | Human | Cervix | HSIL_HPV | 8.88e-06 | 3.21e-01 | 0.0632 |
80271 | ITPKC | T1 | Human | Cervix | CC | 5.42e-03 | 2.93e-01 | 0.0918 |
80271 | ITPKC | T3 | Human | Cervix | CC | 4.27e-06 | 2.48e-01 | 0.1389 |
80271 | ITPKC | AEH-subject1 | Human | Endometrium | AEH | 1.23e-22 | 6.43e-01 | -0.3059 |
80271 | ITPKC | AEH-subject4 | Human | Endometrium | AEH | 4.85e-11 | 5.57e-01 | -0.2657 |
80271 | ITPKC | AEH-subject5 | Human | Endometrium | AEH | 8.89e-09 | 4.81e-01 | -0.2953 |
80271 | ITPKC | EEC-subject1 | Human | Endometrium | EEC | 4.31e-20 | 6.05e-01 | -0.2682 |
80271 | ITPKC | EEC-subject2 | Human | Endometrium | EEC | 4.91e-09 | 4.47e-01 | -0.2607 |
80271 | ITPKC | EEC-subject4 | Human | Endometrium | EEC | 6.06e-03 | 3.50e-01 | -0.2571 |
80271 | ITPKC | EEC-subject5 | Human | Endometrium | EEC | 5.53e-07 | 4.24e-01 | -0.249 |
80271 | ITPKC | GSM6177621_NYU_UCEC2_lib1_lib1 | Human | Endometrium | EEC | 3.87e-05 | -7.58e-02 | -0.1934 |
80271 | ITPKC | GSM6177622_NYU_UCEC3_lib1_lib1 | Human | Endometrium | EEC | 2.54e-03 | 5.62e-03 | -0.1917 |
80271 | ITPKC | LZE7T | Human | Esophagus | ESCC | 3.32e-03 | -4.57e-02 | 0.0667 |
80271 | ITPKC | LZE8T | Human | Esophagus | ESCC | 7.15e-06 | 3.03e-01 | 0.067 |
Page: 1 2 3 4 5 6 |
Transcriptomic changes along malignancy continuum. |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
Figure of enriched GO biological processes. |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | |
Colorectum | SER | |
Colorectum | MSS | |
Colorectum | MSI-H | |
Colorectum | FAP |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
Enriched GO biological processes. |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00086544 | Esophagus | ESCC | phospholipid biosynthetic process | 162/8552 | 253/18723 | 2.59e-09 | 5.73e-08 | 162 |
GO:00464744 | Esophagus | ESCC | glycerophospholipid biosynthetic process | 135/8552 | 211/18723 | 5.75e-08 | 1.02e-06 | 135 |
GO:00450175 | Esophagus | ESCC | glycerolipid biosynthetic process | 154/8552 | 252/18723 | 5.20e-07 | 6.96e-06 | 154 |
GO:00066446 | Esophagus | ESCC | phospholipid metabolic process | 218/8552 | 383/18723 | 5.37e-06 | 5.59e-05 | 218 |
GO:00060668 | Esophagus | ESCC | alcohol metabolic process | 202/8552 | 353/18723 | 7.32e-06 | 7.26e-05 | 202 |
GO:00066505 | Esophagus | ESCC | glycerophospholipid metabolic process | 174/8552 | 306/18723 | 4.92e-05 | 3.85e-04 | 174 |
GO:00464864 | Esophagus | ESCC | glycerolipid metabolic process | 211/8552 | 392/18723 | 6.51e-04 | 3.46e-03 | 211 |
GO:00461653 | Esophagus | ESCC | alcohol biosynthetic process | 83/8552 | 140/18723 | 8.04e-04 | 4.16e-03 | 83 |
GO:19016174 | Esophagus | ESCC | organic hydroxy compound biosynthetic process | 128/8552 | 237/18723 | 5.86e-03 | 2.16e-02 | 128 |
GO:00066611 | Esophagus | ESCC | phosphatidylinositol biosynthetic process | 73/8552 | 131/18723 | 1.31e-02 | 4.28e-02 | 73 |
GO:00060667 | Oral cavity | OSCC | alcohol metabolic process | 179/7305 | 353/18723 | 4.54e-06 | 5.21e-05 | 179 |
GO:00086543 | Oral cavity | OSCC | phospholipid biosynthetic process | 130/7305 | 253/18723 | 3.96e-05 | 3.46e-04 | 130 |
GO:00461652 | Oral cavity | OSCC | alcohol biosynthetic process | 77/7305 | 140/18723 | 8.77e-05 | 6.70e-04 | 77 |
GO:19016173 | Oral cavity | OSCC | organic hydroxy compound biosynthetic process | 115/7305 | 237/18723 | 1.73e-03 | 8.18e-03 | 115 |
GO:00464743 | Oral cavity | OSCC | glycerophospholipid biosynthetic process | 102/7305 | 211/18723 | 3.50e-03 | 1.48e-02 | 102 |
GO:00066445 | Oral cavity | OSCC | phospholipid metabolic process | 175/7305 | 383/18723 | 4.21e-03 | 1.71e-02 | 175 |
GO:00461654 | Skin | cSCC | alcohol biosynthetic process | 50/4864 | 140/18723 | 6.73e-03 | 3.27e-02 | 50 |
Page: 1 |
Enriched KEGG pathways. |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
Annotation of somatic variants for genes involved in malignant transformation |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
ITPKC | SNV | Missense_Mutation | novel | c.1702N>G | p.Phe568Val | p.F568V | Q96DU7 | protein_coding | deleterious(0) | probably_damaging(0.987) | TCGA-EO-A3B0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD |
ITPKC | SNV | Missense_Mutation | rs757405879 | c.1657N>T | p.Arg553Trp | p.R553W | Q96DU7 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-EO-A3KW-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unspecific | SD | |
ITPKC | SNV | Missense_Mutation | novel | c.1793N>A | p.Cys598Tyr | p.C598Y | Q96DU7 | protein_coding | deleterious(0) | benign(0.015) | TCGA-PG-A917-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
ITPKC | insertion | Frame_Shift_Ins | novel | c.1825_1826insC | p.Phe611LeufsTer49 | p.F611Lfs*49 | Q96DU7 | protein_coding | TCGA-BG-A0MQ-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
ITPKC | SNV | Missense_Mutation | novel | c.1561N>T | p.Ala521Ser | p.A521S | Q96DU7 | protein_coding | deleterious(0) | probably_damaging(0.971) | TCGA-DD-A73E-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
ITPKC | SNV | Missense_Mutation | novel | c.1377N>T | p.Met459Ile | p.M459I | Q96DU7 | protein_coding | tolerated(0.21) | benign(0) | TCGA-75-6211-01 | Lung | lung adenocarcinoma | Female | Unknown | I/II | Unknown | Unknown | PD |
ITPKC | SNV | Missense_Mutation | novel | c.292N>C | p.Ala98Pro | p.A98P | Q96DU7 | protein_coding | deleterious_low_confidence(0) | benign(0) | TCGA-95-7043-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
ITPKC | SNV | Missense_Mutation | novel | c.1977G>T | p.Glu659Asp | p.E659D | Q96DU7 | protein_coding | deleterious(0.01) | possibly_damaging(0.526) | TCGA-MN-A4N4-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ITPKC | SNV | Missense_Mutation | rs780537334 | c.293C>T | p.Ala98Val | p.A98V | Q96DU7 | protein_coding | deleterious_low_confidence(0) | benign(0.011) | TCGA-NJ-A4YP-01 | Lung | lung adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
ITPKC | SNV | Missense_Mutation | c.1773N>G | p.Ile591Met | p.I591M | Q96DU7 | protein_coding | deleterious(0) | probably_damaging(0.972) | TCGA-34-5231-01 | Lung | lung squamous cell carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 |
Top |
Related drugs of malignant transformation related genes |
Identification of chemicals and drugs interact with genes involved in malignant transfromation |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
80271 | ITPKC | ENZYME, KINASE | inhibitor | 336446934 | ||
80271 | ITPKC | ENZYME, KINASE | Immunoglobulins | 21987091 |
Page: 1 |